OSLO, NORWAY – 24 September 2021: Reference is made to the press release on 20 September 2021 from Genetic Analysis AS (“the Company”, XSAT ticker: GEAN) regarding the minutes from the Extraordinary General Meeting deciding on the issue of a share capital increase of 7,700,00 new shares and in total 10,010,000 warrants.
The share capital increase pertaining to the 7,700,00 new shares was registered in the Norwegian Register of Business Enterprises yesterday. Following the registration, the share capital of Genetic Analysis AS is NOK 14,949,787.20 divided on 24,916,312 shares, each with a nominal value of NOK 0.60. In addition, 10,010,000 warrants have been issued.
The first day of trading in the shares on Spotlight Stock Market is expected to be on Friday 1 October 2021 under the ticker “GEAN”.
For more information, please contact:
Eilert Aamodt, CFO